Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN105001114B offers high-purity Iopromide preparation. Reduces by-products and simplifies supply chain for contrast agent manufacturing.
Patent CN102336703B details a green Bi2O3-catalyzed oxidation and HATU coupling route for Roflumilast, offering superior yield and supply chain reliability for global pharma buyers.
Patent CN103012256B details a safer sodium amide catalyzed route for roflumilast. This method ensures high purity and yield while reducing hygroscopic risks for supply chains.
Advanced synthesis of liver-targeting ligand via nucleophilic substitution. High yield, scalable process for pharmaceutical intermediates reducing production costs.
Patent CN111116510B discloses a mild cobalt-catalyzed route for dihydrobenzothiazole derivatives, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106966990A reveals metal-free synthesis. High yield, mild conditions. Reliable pharmaceutical intermediates supplier for cost reduction.
Patent CN110885357B details nanofiltration purification for glutamine dipeptide ensuring high purity and reduced energy consumption for reliable supply chains.
Patent CN114958699A reveals a novel dual-enzyme co-expression strategy for ursodeoxycholic acid, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101979391A details a novel mixed catalyst method for Tiotropium Bromide, ensuring EP-compliant isomer levels and robust supply chain reliability for global pharmaceutical manufacturers.
Patent CN106967155B details mild liquid phase oxytocin synthesis ensuring high purity and potency offering significant supply chain cost reduction advantages for pharmaceutical manufacturers.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Patent CN107557412A details immobilized enzyme catalysis for NADPH. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN105200076A reveals high-purity gamma-lactam production. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN112940053B reveals a streamlined route for anti-HCV drugs, offering high purity and industrial scalability for reliable supply chains.
Patent CN118580187A reveals green chlorophyll photocatalysis for dihydroisoquinolone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Discover a novel metal-free synthesis of Tegafur using organic ammonium salts. This patent offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101823946A details a green synthesis for Abafungin intermediates using hydantoin reagents. Achieves 95% conversion with minimal purification, offering significant supply chain advantages.
Patent CN104178533B details enzymatic synthesis of R-3-aminobutanol. Offers high purity, cost efficiency, and scalable supply chain solutions for global pharmaceutical manufacturers.
Novel biocatalytic method for S-2-(4-nitrophenyl)oxirane production. Delivers high purity, cost-effective, and scalable processes for global pharmaceutical intermediate supply chains.
Novel synthetic route for 1-hydroxy-pyrrolo[2,3-c]piperidine via TosMIC cyclization. Reduces production risks and costs for moxifloxacin intermediates.